TB-500 + BPC-157 — is the synergy real or is it just running two things and giving both credit?

Honestly? I can't separate them either. Ran BPC alone in 2022, BPC+TB in 2023, similar injuries both years, recovery curves looked close. The stack felt more 'systemic' but the objective markers weren't obviously different.

For partial thickness rotator cuff specifically — my take is TB does more work than BPC for the big systemic 'iron' feel, BPC does more for the specific pin-site-adjacent tendon. Running both isn't redundant for my profile, it's additive on different axes.

I've done TB alone twice. For tendinopathy it did less than I expected on its own. Felt better systemically but the specific tendon didn't improve as fast as BPC-only runs. Stack for me is where it lands.

The synergy claim would be testable if anyone ran TB alone for a rehab cycle. Almost no one does because BPC is cheap and safe and nobody wants to leave it out. Which is how you get stuck with permanent confounding.

The mechanism overlap — angiogenesis, cell migration, tissue repair — arguably predicts synergy because they're hitting the same process via different handles. But 'predicts synergy' and 'observable synergy in a single human rehab cycle' are lightyears apart.

Pre-op I ran only BPC. Post-op I'm running the stack. I'll never be able to say what TB added. But I'm not willing to hold it out for the sake of experimental purity while I have a real surgery to recover from.

@acl_again this is the honest framing. Recovery-under-real-injury isn't a lab setting, you stack what the community consensus supports and accept you'll never fully parse the contributions.

My rule: if the injury is localized + tendinous, BPC alone. If there's systemic inflammation/multiple sites/chronic/global stiffness component, add TB. Doesn't make the synergy scientifically clean but it gives me a decision framework.

'Running two compounds, feeling better, giving both credit' is literally the definition of a confounded experiment. We're not going to resolve this on a forum. What we can do is get better at logging — so at least we know what we ran and what changed.

Related point — the cost of the stack is meaningful. If BPC alone gets you 80% of the way, adding TB at a $100-400/cycle premium is an expensive 20%. Worth quantifying whether you'd pay that if you knew it was 20%.

Meniscus repair here. I ran TB alone first cycle (6 weeks), added BPC second cycle (6 weeks). The addition of BPC changed the joint-specific pain response notably. TB alone didn't touch it. So for my profile BPC was doing the local work and TB was backdrop.

Great thread. Consensus read: 'synergy' is probably overclaimed, division of labor is a better model (BPC local, TB systemic), and both have an injury profile where they do most of the work. Cost/value depends on which one your specific problem maps to.

Bookmarking. Best thread I've read on this stack in 6 months.

@bpc_baby for most cases, yes. BPC alone first, assess at 4-6 weeks, add TB if you're chasing a systemic effect or hitting a plateau. Don't start with the full stack if you don't need it — you won't know what's doing what.

For newbies reading this — is the right first move BPC alone, and add TB if BPC alone isn't cutting it?